Clinical Trials
34 trialsCISTO
University of Washington
EV-309
Astellas Pharma Inc
The COOKER-BLADDER Trial
Hospital Centre Biel/Bienne
INCyst
Centre Hospitalier Universitaire Vaudois
RAD-VACCINE
The Methodist Hospital Research Institute
TURANDORELA
The Netherlands Cancer Institute
FMBRT
Cedars-Sinai Medical Center
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology LLC
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
University of California, Los Angeles
NOCATIN
Jahn Ferenc South Pest Teaching Hospital
Can VI-RADS/ADC Accurately Stage Bladder Cancer??
Mansoura University
Infectious Complications After Cystectomy: A Prospective Observational Study
Ludwig-Maximilians - University of Munich
Trimodality Treatment in Bladder Cancer
Consorci Sanitari de Terrassa
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Ikena Oncology
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
IRCCS San Raffaele
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-GuƩrin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
H. Lee Moffitt Cancer Center and Research Institute
PHRC2003
Institut BergoniƩ
TACBIN-01
RenJi Hospital
Eosinophilic Cystitis Mimicking Urothelial Neoplasia
Al-Azhar University
A Trial of a Modified Cystoscopy Method to Reduce Pain Perception
Western University, Canada
FIERCE-22
Rainier Therapeutics
FIERCE-21
Rainier Therapeutics
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
Mansoura University
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
Endo Pharmaceuticals
EMBARC-RF
Bioniche Life Sciences Inc.
OPTIMA
UroGen Pharma Ltd.
Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients
UroGen Pharma Ltd.
Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients
UroGen Pharma Ltd.
NMIBC TURBT HG
UroGen Pharma Ltd.
SHTC-EUROPE-1
Medical Enterprises Europe B.V.
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-GuƩrin Immunotherapy (BCG) for Superficial Bladder Cancer
Medical Enterprises Europe B.V.
Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure
Tengion